Fox Chase Cancer Center Sponsors First NCI-Supported Conference on Behavioral and Psychosocial Aspects of Cancer Prevention
PHILADELPHIA (October 20, 2000) -- Fox Chase Cancer Center is proud to sponsor the first NCI-supported conference on cancer prevention and control focusing on the behavioral psychosocial aspects of cancer prevention. This conference brings together the foremost investigators in cancer prevention to present and integrate emerging scientific findings and to provide a forum for discussing future directions in cancer prevention and bio-behavioral research.
The conference will be held from October 20 - 22, 2000 at the Korman Suites Hotel in Philadelphia PA. Please see the attached brochure for further details. We look forward to seeing you at this exciting and state-of-the-art conference.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.